UHRF2 and cancer: Although UHRF2 is less frequently overexpressed in cancers in comparison with UHRF1 (Figure 5c and d) and is therefore less responsible for downregulation of DNMT3A in cancers, in a few cancer cell lines, especially A549, UHRF2 appears to play a dominant role in negative regulation of DNMT3A.